ARKEMA OTC Stock Today

ARKAF -  USA Stock  

USD 126.40  0.00  0.00%

ARKEMA SA is trading at 126.40 as of the 25th of July 2021, a No Change since the beginning of the trading day. The stock's lowest day price was 126.4. ARKEMA SA has about a 36 percent probability of financial distress in the next few years of operation and did not have a very good performance during the last 90 trading days. Equity ratings for ARKEMA SA are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 26th of April 2021 and ending today, the 25th of July 2021. Click here to learn more.
 Market Performance
6 of 100
  Odds Of Distress
Less than 36
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

ARKEMA SA OTC Stock Profile

Arkema S.A. manufactures and sells specialty chemicals and advanced materials worldwide. Arkema S.A. was incorporated in 2003 and is headquartered in Colombes, France. ARKEMA SA operates under Specialty Chemicals classification in the United States and is traded on OTC Exchange. It employs 19794 people. more on ARKEMA SA
About 13.0% of the company shares are held by company insiders
Latest headline from Are Arkema S.A.s Mixed Financials Driving The Negative Sentiment - Simply Wall St
ChairmanThierry Henaff  (View All)
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of ARKEMA SA's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
ARKEMA SA [ARKAF] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Mid-Cap' category with current market capitalization of 9.58 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate ARKEMA SA's market, we take the total number of its shares issued and multiply it by ARKEMA SA's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. ARKEMA SA classifies itself under Basic Materials sector and is part of Specialty Chemicals industry. The entity has 75.83 M outstanding shares. ARKEMA SA has accumulated about 1.49 B in cash with 1.16 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 19.52.
Check ARKEMA SA Probability Of Bankruptcy
ARKEMA SA holds a total of seventy-five million eight hundred thirty thousand outstanding shares. Over half of ARKEMA SA outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Thus, these institutions are subject to different rules and regulation than regular investors in ARKEMA SA. Please watch out for any change in the institutional holdings of ARKEMA SA as this could mean something significant has changed or about to change at the company. Please note that no matter how much assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Ownership Allocation (%)

Check ARKEMA Ownership Details

ARKEMA Stock Price Odds Analysis

What are ARKEMA SA's target price odds to finish over the current price? Based on a normal probability distribution, the odds of ARKEMA SA jumping above the current price in 90 days from now is about 66.09%. The ARKEMA SA probability density function shows the probability of ARKEMA SA otc stock to fall within a particular range of prices over 90 days. Assuming the 90 days horizon ARKEMA SA has a beta of -0.182. This suggests as returns on benchmark increase, returns on holding ARKEMA SA are expected to decrease at a much lower rate. During the bear market, however, ARKEMA SA is likely to outperform the market. Additionally, the company has an alpha of 0.1004, implying that it can generate a 0.1 percent excess return over DOW after adjusting for the inherited market risk (beta).
 Odds Down 126.4HorizonTargetOdds Up 126.4 
33.57%90 days
Based on a normal probability distribution, the odds of ARKEMA SA to move above the current price in 90 days from now is about 66.09 (This ARKEMA SA probability density function shows the probability of ARKEMA OTC Stock to fall within a particular range of prices over 90 days) .

ARKEMA SA Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. ARKEMA SA market risk premium is the additional return an investor will receive from holding ARKEMA SA long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in ARKEMA SA. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although ARKEMA SA's alpha and beta are two of the key measurements used to evaluate ARKEMA SA's performance over the market, the standard measures of volatility play an important role as well.

ARKEMA Stock Against Markets

Picking the right benchmark for ARKEMA SA otc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in ARKEMA SA otc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for ARKEMA SA is critical whether you are bullish or bearish towards ARKEMA SA at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in ARKEMA SA without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Fund Screener Now


Fund Screener

Find activelly-traded funds from around the world traded on over 30 global exchanges
All  Next Launch Module

ARKEMA SA Corporate Directors

ARKEMA SA corporate directors refer to members of an ARKEMA SA board of directors. The board of directors generally takes responsibility for the ARKEMA SA's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of ARKEMA SA's board members must vote for the resolution. The ARKEMA SA board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Patrice Breant - Director - Shareholder Employees RepresentativeProfile
JeanMarc Bertrand - Non-Executive Director Representing Shareholder EmployeesProfile
Victoire Margerie - Independent DirectorProfile
Helene MoreauLeroy - Non-Executive Independent DirectorProfile
Please continue to Trending Equities. Note that the ARKEMA SA information on this page should be used as a complementary analysis to other ARKEMA SA's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Complementary Tools for ARKEMA OTC Stock analysis

When running ARKEMA SA price analysis, check to measure ARKEMA SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ARKEMA SA is operating at the current time. Most of ARKEMA SA's value examination focuses on studying past and present price action to predict the probability of ARKEMA SA's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move ARKEMA SA's price. Additionally, you may evaluate how the addition of ARKEMA SA to your portfolios can decrease your overall portfolio volatility.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Money Managers
Screen money managers from public funds and ETFs managed around the world
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
The market value of ARKEMA SA is measured differently than its book value, which is the value of ARKEMA that is recorded on the company's balance sheet. Investors also form their own opinion of ARKEMA SA's value that differs from its market value or its book value, called intrinsic value, which is ARKEMA SA's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ARKEMA SA's market value can be influenced by many factors that don't directly affect ARKEMA SA underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ARKEMA SA's value and its price as these two are different measures arrived at by different means. Investors typically determine ARKEMA SA value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ARKEMA SA's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.